Sitemap
Update: July 26th, 2009
Sitemap of posts on Orshe.com
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64
Posts
- Category: Wall Street Journal (continued)
- After Defeat in Senate Finance, What’s Next for Public Option?
- After Errors, Hospital Must Put Video Cameras in ORs
- After FDA Warning, J&J Yanks Online Video for Pain Med
- After Genetech Deal, Roche Says ‘So Long, PhRMA; Hello, BIO’
- After Google-Apple, Can Biogen Directors Sit on Genzyme Board?
- After Jackson’s Death, Tracking Causes of Sudden Cardiac Arrest
- After Patent Expires, Pfizer Staying with Lipitor
- After Protracted Battles, FDA Nears Wider Use of Plan B
- After White House and Congress, Health Bill Headed for Courts
- Again With the Nuclear Medicine Shortage
- Aging Brains Benefit from Fish
- AIDS Risk Strong on the Doorstep of U.S. Capitol
- AIDS Vaccine Trial: Why a ‘Modest’ Benefit Is Notable
- Air Pollution Choking Hong Kong
- Air Travelers Warned About Possible Measles Exposure
- All Drug Marketing Is Local
- All That Stuff About Buying Into Medicare At 55? We Take It Back.
- Allergan Now Batting .500 in Botox Lawsuits
- Allscripts CEO Talks Merger, ‘Meaningful Use’ and iPads
- Almost 5% of Americans Report Falling Asleep at the Wheel
- Almost Half of Americans Took a Prescription Drug in Past Month
- Alternative Chronic Pain Remedies Get New Focus
- Alternatives to the ER
- Always Think You Stink? Maybe You Have ‘Olfactory Reference Disorder’
- Alzheimer Diagnosis Possible With Scan
- Alzheimer Patients Clamor for Skin-Cancer Drug
- Alzheimer’s Cases to Climb Sharply With Longer Lifespans
- Alzheimer’s Drug Development a Tough Road, Lilly News Shows
- Alzheimer’s, Aging and the Brain
- AM Report: Hope Fades for Bright Q3
- AM Report: Big Health Insurer Enters Fray
- AM Report: Businesses Fear Health Costs
- AM Report: China's Hu Heads to Capitol Hill
- AM Report: ECB Aims to Soothe Liquidity Fears
- AM Report: Election Shock: Key Industries See Hope
- AM Report: Final Health Vote Nears
- AM Report: GOP Aims to Erode Obama's Agenda
- AM Report: Health Battle Lines Drawn
- AM Report: Health Bill Hits Snag
- AM Report: Health Bill Passes
- AM Report: Health Insurers: Rate Hikes Coming Soon
- AM Report: Hot Business Issues on Capitol Hill
- AM Report: Job Losses Accelerate
- AM Report: Kraft Ignites A Chocolate War
- AM Report: McDonald's May Drop Health Plan
- AM Report: Medicare Expansion Stalls
- AM Report: Obama Tackles Insurers
- AM Report: Obama Tearing into GOP
- AM Report: Public Option Compromise
- AM Report: Republicans Put Spending in Cross Hairs
- AM Report: Senate Passes Health Bill
- AM Report: U.S., Japan Differ on Radiation Danger
- AM Report: Will Health Summit Work?
- AM Vitals: New York Budget Pact Takes Aim at Medicaid Spending
- AM Vitals: A Propensity for Surgery
- AM Vitals: Federal drug-store raids widen in probe of pain pill abuse.
- AM Vitals: More Freedom for Pacemaker Wearers, HIV Risk and Less Diaper Shopping
- AMA Ads Say Senate ‘Took a Vacation’ Instead of Fixing Medicare
- AMA Looks to Put Brakes on Debt Load of Med Students
- AMA on End-of-Life Debate: ‘Egregious … Mischaracterization’
- AMA Prez-Elect: What Docs Want In Exchange for Curbing Costs
- AMA to Competitive Eaters: Put Down that Hot Dog!
- AMA Warns of ‘Catastrophe’ Without 13-Month ‘Doc Fix’
- AMA Weighs in on ‘Meaningful Use’ Requirements For E-Records
- AMA Weighs Whether Docs Should Hang Up Their White Coats
- AMA, Hospitals Back Senate Health Bill; Insurers Still Opposed
- AMA: the White Coats Are Going, the White Coats Are Going
- Ambulances Get an Upgrade
- Amendment to Repeal Health Bill Tax Provision Fails; Prevention Fans Cheer
- American Council on Exercise: Study Finds Toning Shoes Don’t Work
- American Medical Association CEO Michael Maves to Leave in June
- Americans Rate Their Own Health Care Highly, But Income Matters
- Americans Spend $34 Billion a Year on ‘Alternative’ Medicine
- Amgen and J&J Anemia Drugs Recalled on Concerns of Glass Flakes
- Amgen Gets a Lift
